Pituitary & hypothalamus

Hypothalamic–pituitary–adrenal axis activity in patients with primary polydipsia compared to healthy controls

Clin Endocrinol (Oxf)Published Exploratory analysis of two prospective observational studies

Primary result · HPA axis activityResult — go to the resultEstimated difference −3.7 nmol/L 95% CI −5.5 to −1.8

Authors' conclusion

Our results suggest no difference in HPA axis activity between patients with primary polydipsia and healthy controls. The observed difference in salivary cortisol levels may be linked to a dilution effect in saliva rather than an altered stress axis considering the other findings.

Study context

Population
Patients with primary polydipsia and healthy controls
Participants
34 vs 20
Comparison
Primary polydipsia vs healthy controls
  • Primary polydipsian = 34
  • Healthy controlsn = 20reference
Primary endpoint
Difference in hypothalamic-pituitary-adrenal (HPA) axis activity: circadian serum and salivary cortisol, 24-h UFC, cortisol before and after adrenocorticotropic hormone (ACTH) stimulation (Wilcoxon rank-sum test)

Primary result

HPA axis activity

Estimated difference

−3.7 nmol/L

95% CI −5.5 to −1.8

P < 0.001

Primary polydipsiavs Healthy controls
estimated difference −3.7 nmol/L (95% CI −5.5 to −1.8); P < 0.001

As reported in the abstract

Further findings

OutcomeP value
Fasting copeptin (vasopressin suppression)Significantly lower with primary polydipsiaP < 0.01

Original publication

Hypothalamic–pituitary–adrenal axis activity in patients with primary polydipsia compared to healthy controls. Clin Endocrinol (Oxf). Published 30 November 2022. doi:10.1111/cen.14835

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.